{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T02:21:33Z","timestamp":1772850093606,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["IZS AM 01\/10 RC"],"award-info":[{"award-number":["IZS AM 01\/10 RC"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.actatropica.2022.106498","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T02:00:28Z","timestamp":1651456828000},"page":"106498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Immunogenicity and safety studies of an inactivated vaccine against Rift Valley fever"],"prefix":"10.1016","volume":"232","author":[{"given":"Gaetano Federico","family":"Ronchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilia","family":"Testa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4796-4312","authenticated-orcid":false,"given":"Mariangela","family":"Iorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Pinoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grazia","family":"Bortone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Capobianco","family":"Dondona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Capista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Mercante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Di Ventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Monaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2022.106498_bib0001","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.intimp.2018.07.004","article-title":"Effect of butylated hydroxyl toluene on the immune response of Rift Valley fever vaccine in a murine model","volume":"62","author":"Abo-El-Sooud","year":"2018","journal-title":"Int. Immunopharmacol"},{"key":"10.1016\/j.actatropica.2022.106498_bib0002","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7346294","article-title":"Safety and efficacy profile of commercial veterinary vaccines against rift valley fever: a review study","volume":"2016","author":"Alhaj","year":"2016","journal-title":"J. Immunol. Res."},{"issue":"12","key":"10.1016\/j.actatropica.2022.106498_bib0003","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.3201\/eid1912.121527","article-title":"Epidemiologic investigations into outbreaks of Rift Valley Fever in Humans, South Africa, 2008-2011","volume":"19","author":"Archer","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.actatropica.2022.106498_bib0004","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vetimm.2018.01.001","article-title":"Expression of cytokines following vaccination of goats with a recombinant capripoxvirus vaccine expressing Rift Valley fever virus proteins","volume":"197","author":"Ayari-Fakhfakh","year":"2018","journal-title":"Vet. Immunol. Immunopathol"},{"issue":"6","key":"10.1016\/j.actatropica.2022.106498_bib0005","article-title":"Safety and immunogenicity of the Rift Valley fever arMP-12 \u0394NSm21\/384 candidate vaccine in pregnant ewes","volume":"29","author":"Boumart","year":"2020","journal-title":"Vaccine X."},{"issue":"1","key":"10.1016\/j.actatropica.2022.106498_bib0006","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12917-018-1596-8","article-title":"Rift Valley fever seroprevalence and abortion frequency among livestock of Kisoro district, South Western Uganda (2016): a prerequisite for zoonotic infection","volume":"14","author":"Budasha","year":"2018","journal-title":"BMC Vet. Res."},{"issue":"7","key":"10.1016\/j.actatropica.2022.106498_bib0007","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1089\/vbz.2009.0205","article-title":"Experimental infection of young adult European breed sheep with Rift Valley fever virus field isolates","volume":"10","author":"Busquets","year":"2010","journal-title":"Vector Borne Zoonotic Dis."},{"issue":"1","key":"10.1016\/j.actatropica.2022.106498_bib0008","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3201\/eid2201.150725","article-title":"Rift Valley fever virus among Wild Ruminants, Etosha National Park, Namibia, 2011","volume":"22","author":"Capobianco Dondona","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.actatropica.2022.106498_bib0009","series-title":"Vaccins pour l'usage v\u00e9t\u00e9rinaire","first-page":"628","year":"2004"},{"issue":"12","key":"10.1016\/j.actatropica.2022.106498_bib0010","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3390\/v12121453","article-title":"Genetic diversity of Rift Valley fever strains circulating in Namibia in 2010 and 2011","volume":"12","author":"Cosseddu","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.actatropica.2022.106498_bib0011","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/path.1700340418","article-title":"Enzootic hepatitis or rift valley fever. An undescribed virus disease of sheep cattle and man from east Africa","volume":"34","author":"Daubney","year":"1931","journal-title":"J. Pathol. Bacteriol"},{"issue":"2","key":"10.1016\/j.actatropica.2022.106498_bib0012","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1017\/S0022172400061441","article-title":"Rift Valley fever in Kenya: the presence of antibody to the virus in camels (Camelus dromedarius)","volume":"94","author":"Davies","year":"1985","journal-title":"J. Hyg. (Lond)."},{"key":"10.1016\/j.actatropica.2022.106498_bib0013","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.provac.2011.07.015","article-title":"Adjuvant formulation for companion animals vaccines","volume":"4","author":"Deville","year":"2011","journal-title":"Procedia Vaccinol."},{"issue":"6","key":"10.1016\/j.actatropica.2022.106498_bib0014","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/vim.2014.0113","article-title":"Use of adjuvants to enhance the immune response induced by a DNA vaccine against Bovine Herpesvirus-1","volume":"28","author":"Di Giacomo","year":"2015","journal-title":"Viral Immunol"},{"issue":"20","key":"10.1016\/j.actatropica.2022.106498_bib0015","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.vaccine.2016.03.061","article-title":"Potency of a thermostabilised chimpanzee adenovirus Rift Valley Fever vaccine in cattle","volume":"34","author":"Dulal","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2022.106498_bib0016","first-page":"61","article-title":"Vaccination for the control of Rift Valley fever in enzootic and epizootic situations","volume":"135","author":"Dungu","year":"2013","journal-title":"Dev. Biol. (Basel)."},{"key":"10.1016\/j.actatropica.2022.106498_bib0017","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.coviro.2018.02.001","article-title":"Rift Valley fever vaccines: current and future needs","volume":"29","author":"Dungu","year":"2018","journal-title":"Curr. Opin. Virol."},{"issue":"3","key":"10.1016\/j.actatropica.2022.106498_bib0018","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/vaccines5030029","article-title":"Current status of Rift Valley fever vaccine development","volume":"5","author":"Faburay","year":"2017","journal-title":"Vaccines"},{"issue":"1-2","key":"10.1016\/j.actatropica.2022.106498_bib0019","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.vetmic.2006.11.008","article-title":"Cloning and expression of Rift Valley fever virus nucleocapsid (N) protein and evaluation of a N-protein based indirect ELISA for the detection of specific IgG and IgM antibodies in domestic ruminants","volume":"121","author":"Fafetine","year":"2007","journal-title":"Vet. Microbiol."},{"issue":"2","key":"10.1016\/j.actatropica.2022.106498_bib0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3390\/v11020139","article-title":"The one health approach is necessary for the control of Rift Valley Fever infections in Egypt: a comprehensive review","volume":"11","author":"Fawzy","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.actatropica.2022.106498_bib0021","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.actatropica.2018.11.022","article-title":"Efficacy of Montanide (IMS 3015) as an adjuvant for an inactivated Rift Valley fever (RVF) vaccine in sheep","volume":"190","author":"Hussein","year":"2019","journal-title":"Acta Trop."},{"issue":"7","key":"10.1016\/j.actatropica.2022.106498_bib0022","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.sjbs.2018.08.019","article-title":"Development of Rift Valley fever (RVF) vaccine by genetic joining of the RVF-glycoprotein Gn with the strong adjuvant subunit B of cholera toxin (CTB) and expression in bacterial system","volume":"26","author":"Ibrahim","year":"2019","journal-title":"Saudi J. Biol. Sci."},{"issue":"Suppl 4","key":"10.1016\/j.actatropica.2022.106498_bib0023","doi-asserted-by":"crossref","first-page":"D69","DOI":"10.1016\/j.vaccine.2009.07.046","article-title":"Rift valley fever vaccines","volume":"27","author":"Ikegami","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2022.106498_bib0024","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fcimb.2012.00131","article-title":"Novel approaches to develop Rift Valley fever vaccines","volume":"2","author":"Indran","year":"2012","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.actatropica.2022.106498_bib0025","unstructured":"International Committee on Taxonomy of Viruses. 2022 https:\/\/ictv.global\/taxonomy\/."},{"issue":"1-2","key":"10.1016\/j.actatropica.2022.106498_bib0026","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jviromet.2006.11.005","article-title":"Preparation and evaluation of a recombinant Rift Valley fever virus N protein for the detection of IgG and IgM antibodies in humans and animals by indirect ELISA","volume":"140","author":"Jansen van Vuren","year":"2007","journal-title":"J. Virol. Methods."},{"issue":"6","key":"10.1016\/j.actatropica.2022.106498_bib0027","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.vaccine.2020.11.071","article-title":"A plasmid encoding the extracellular domain of CD40 ligand and Montanide\u2122 GEL01 as adjuvants enhance the immunogenicity and the protection induced by a DNA vaccine against BoHV-1","volume":"39","author":"Kornuta","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2022.106498_bib0028","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.antiviral.2014.03.008","article-title":"One Health approach to Rift Valley fever vaccine development","volume":"106","author":"Kortekaas","year":"2014","journal-title":"Antiviral Res."},{"issue":"46","key":"10.1016\/j.actatropica.2022.106498_bib0029","doi-asserted-by":"crossref","first-page":"6534","DOI":"10.1016\/j.vaccine.2012.08.052","article-title":"Stability of a formalin-inactivated Rift Valley fever vaccine: evaluation of a vaccination campaign for cattle in Mozambique","volume":"30","author":"Lagerqvist","year":"2012","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.actatropica.2022.106498_bib0030","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1099\/jgv.0.000765","article-title":"Rift Valley fever virus: strategies for maintenance, survival and vertical transmission in mosquitoes","volume":"98","author":"Lumley","year":"2017","journal-title":"J. Gen. Virol."},{"issue":"12","key":"10.1016\/j.actatropica.2022.106498_bib0031","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1292\/jvms.19-0399","article-title":"Protective efficacy of inactivated reverse genetics based equine influenza vaccine candidate adjuvanted with MontanideTM Pet Gel in murine model","volume":"81","author":"Mathew","year":"2019","journal-title":"J. Vet. Med. Sci."},{"issue":"12","key":"10.1016\/j.actatropica.2022.106498_bib0032","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3201\/eid1912.130593","article-title":"Rift Valley fever in Namibia, 2010","volume":"19","author":"Monaco","year":"2013","journal-title":"Emerg. Infect. Dis."},{"issue":"11","key":"10.1016\/j.actatropica.2022.106498_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142129","article-title":"First external quality assessment of molecular and serological detection of Rift Valley Fever in the Western Mediterranean region","volume":"10","author":"Monaco","year":"2015","journal-title":"PLoS One."},{"issue":"4","key":"10.1016\/j.actatropica.2022.106498_bib0034","doi-asserted-by":"crossref","first-page":"e1623","DOI":"10.1371\/journal.pntd.0001623","article-title":"Innate immune response to Rift Valley fever virus in goats","volume":"6","author":"Nfon","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"3","key":"10.1016\/j.actatropica.2022.106498_bib0035","doi-asserted-by":"crossref","first-page":"e06041","DOI":"10.2903\/j.efsa.2020.6041","article-title":"Rift Valley Fever - epidemiological update and risk of introduction into Europe","volume":"18","author":"Nielsen","year":"2020","journal-title":"EFSA J."},{"issue":"4","key":"10.1016\/j.actatropica.2022.106498_bib0036","first-page":"197","article-title":"Active and passive immunization against Rift Valley fever virus infection in Syrian hamsters","volume":"92","author":"Niklasson","year":"1984","journal-title":"Acta Pathol. Microbiol. Immunol. Scand. C."},{"key":"10.1016\/j.actatropica.2022.106498_bib0037","article-title":"Rift Valley Fever (Infection with Rift Valley Fever Virus)","year":"2018","journal-title":"chapter 3.1.18"},{"key":"10.1016\/j.actatropica.2022.106498_bib0038","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.provac.2009.07.026","article-title":"Adjuvant formulation for veterinary vaccines: Montanide\u2122 Gel safety profile","volume":"1","author":"Parker","year":"2009","journal-title":"Procedia in Vaccinology"},{"issue":"2","key":"10.1016\/j.actatropica.2022.106498_bib0039","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0166-0934(03)00228-3","article-title":"IgG-sandwich and IgM-capture enzyme-linked immunosorbent assay for the detection of antibody to Rift Valley fever virus in domestic ruminants","volume":"113","author":"Paweska","year":"2003","journal-title":"J. Virol. Methods."},{"issue":"1-2","key":"10.1016\/j.actatropica.2022.106498_bib0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jviromet.2004.11.020","article-title":"Validation of IgG-sandwich and IgM-capture ELISA for the detection of antibody to Rift Valley fever virus in humans","volume":"124","author":"Paweska","year":"2005","journal-title":"J. Virol. Methods"},{"issue":"1","key":"10.1016\/j.actatropica.2022.106498_bib0041","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jviromet.2005.02.008","article-title":"An inhibition enzyme-linked immunosorbent assay for the detection of antibody to Rift Valley fever virus in humans, domestic and wild ruminants","volume":"127","author":"Paweska","year":"2005","journal-title":"J. Virol. Methods"},{"issue":"6","key":"10.1016\/j.actatropica.2022.106498_bib0042","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1051\/vetres\/2010033","article-title":"Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention","volume":"41","author":"Pepin","year":"2010","journal-title":"Vet. Res."},{"issue":"9","key":"10.1016\/j.actatropica.2022.106498_bib0043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239478","article-title":"External quality assessment of Rift Valley fever diagnosis in 17 veterinary laboratories of the Mediterranean and Black Sea regions","volume":"15","author":"P\u00e9rez-Ram\u00edrez","year":"2020","journal-title":"PLoS One."},{"issue":"1-2","key":"10.1016\/j.actatropica.2022.106498_bib0044","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0264-410X(99)00218-2","article-title":"Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience","volume":"18","author":"Pittman","year":"1999","journal-title":"Vaccine"},{"issue":"34","key":"10.1016\/j.actatropica.2022.106498_bib0045","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1016\/j.vaccine.2017.05.046","article-title":"Comparative efficacy and toxicity of two vaccine candidates against Sporothrix schenckii using either Montanide\u2122 Pet Gel A or aluminum hydroxide adjuvants in mice","volume":"35","author":"Portuondo","year":"2017","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.actatropica.2022.106498_bib0046","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.vaccine.2016.12.003","article-title":"Vaccination of alpacas against Rift Valley fever virus: Safety, immunogenicity and pathogenicity of MP-12 vaccine","volume":"35","author":"Rissmann","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.actatropica.2022.106498_bib0047","first-page":"67","article-title":"Immunogenicity of two adjuvant formulations of an inactivated African horse sickness vaccine in guinea-pigs and target animals","volume":"48","author":"Ronchi","year":"2012","journal-title":"Vet. Ita."},{"issue":"17","key":"10.1016\/j.actatropica.2022.106498_bib0048","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1016\/j.vaccine.2011.02.037","article-title":"Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study","volume":"29","author":"Rusnak","year":"2011","journal-title":"Vaccine"},{"issue":"1-2","key":"10.1016\/j.actatropica.2022.106498_bib0049","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.vetmic.2007.04.017","article-title":"An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy","volume":"124","author":"Savini","year":"2007","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.actatropica.2022.106498_bib0050","series-title":"Dukes' Physiology of Domestic Animals","first-page":"887","author":"Swenson","year":"2004"},{"issue":"8","key":"10.1016\/j.actatropica.2022.106498_bib0051","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1099\/jgv.0.001296","article-title":"Rift Valley fever: biology and epidemiology","volume":"100","author":"Wright","year":"2019","journal-title":"J. Gen. Virol."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X22001905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X22001905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:35:49Z","timestamp":1757550949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X22001905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":51,"alternative-id":["S0001706X22001905"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2022.106498","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety studies of an inactivated vaccine against Rift Valley fever","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2022.106498","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106498"}}